Eli Lilly Files Lawsuits Against Telehealth Firms Over Unauthorized Weight-Loss Drugs

Eli Lilly & Co. has taken decisive legal action by filing lawsuits in federal courts across Indiana, Texas, and Washington. The lawsuits target three telehealth companies that Eli Lilly accuses of selling unauthorized knockoffs of its weight-loss medications. These medications, according to Eli Lilly, have not received approval from the U.S. Food and Drug Administration (FDA) and are described as posing a potential hazard to patient safety. The company emphasizes the dangers associated with these counterfeit products in its legal proceedings, underscoring the necessity for compliance with FDA guidelines to ensure patient safety. For a deeper understanding of the legal facets and repercussions, further details can be accessed in the article on Law360.